Synonyms: ABT-530 | ABT530 | Mavyret® (glecaprevir + pibrentasvir)
pibrentasvir is an approved drug (EMA & FDA (2017))
Compound class:
Synthetic organic
Comment: Pibrentasvir is an oral, direct-acting inhibitor of hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex. It targets viral RNA replication and viron assembly.
|
|
References |
1. Lawitz EJ, O'Riordan WD, Asatryan A, Freilich BL, Box TD, Overcash JS, Lovell S, Ng TI, Liu W, Campbell A et al.. (2015)
Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection. Antimicrob Agents Chemother, 60 (3): 1546-55. [PMID:26711747] |